4Xu J, Qian Y, Wang S, et al. EV71: an emerging infectious disease vaccine target in the Far East? [J]. Vaccine, 2010,28 (20) : 3516-3521.
5Chang LY, Lee CY, Kao CL, et al. Hand, foot and mouth disease complicated with central nervous system involvement in Taiwanin 1980-1981 [J]. J Formos Med Assoc, 2007,106 (2) :173-176.
6McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance [J ]. FEMS Microbiol Rev, 2002, 26(1):91- 107.
7CHONG J H, AAN M K J. An atypical dermatologic presentation of a child with hand, foot and mouth disease caused by coxsackievirus A6 [ J ]. The Pediatric Infectious Disease Journal, 2014, 35(8) : 889.
8MARSOT M, RAUTUREAU S, DUFOUR B, et al. Impact of stakeholders influence, geographic level and risk perception on strategic decisions in simulated foot and mouth disease epizootics in france [J]. PLoS ONE, 2014, 9( 1 ) : e86 323.
9BAXTER R, CRAIGMILE S C,HALEY C,et al. BoLA- DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle [J ]. Vaccine,2009,28( 1 ): 28-37.
10WANG G X, WANG Y H, SHANG Y J, et al. How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection [J]. Viology Jourual,2015, 12( 1 ): 9.
